Department of Otolaryngology Head and Neck Surgery Division of Research

Active studies that are open to enrollment:


Principle Investigator

Study

C. Baldassari, MD

Quality of Life scores following Adenotonsillectomy for Mild Obstructive Sleep Apnea in Children:a Randomized Prospective Trial  

C. Derkay, MD Hemostatic Control after Adenotonsillectomy - Open Label QuikClot Study
C. Baldassari, MD Turbinate Cauterization in Pediatric Patients with Nasal Obstruction A Randomized Prospective Trial
C. Baldassari, MD,
D. Darrow, MD,
C. Derkay, MD
 The Laryngeal Mask Airway in Pediatric Adenotonsillectomy
C. Baldassari, MD Turbinate Cauterization in Pediatric Patients with Nasal Obstruction A Randomized Prospective Trial

S. Moody Antonio, MD,
B. Strasnick, MD

Cochlear Implant Database 
C. Derkay, MD,
D. Darrow, MD.
OK-432 (Picibanil) Sclerotherapy- A Multi-Center Trial (Treatment of Life-Threatening Lymphangiomas)
C. Derkay, MD,
D. Darrow, MD,
J. Sinacori, MD
Genetic Susceptibility in Recurrent Respiratory Papillomatosis - RC3145
C. Derkay, MD,
D. Darrow, MD,
C. Baldassari, MD
A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of Ciprofloxacin 0.3% plus Fluocinolone Acetonide 0.025% Otic Solution Compared to Ciprofloxacin 0.3% Otic Solution and to Fluocinolone Acetondie 0.025% Otic Solution in the Treatment of Acute Otitis Media with Tympanostomy Tubes in Pediatric Patients.

Sub Investigators

Study

D. Karakla, MD,
M. Bak, MD
RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
D. Karakla, MD,
M. Bak, MD
RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
D. Karakla, MD,
M. Bak, MD
RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
D. Karakla, MD,
M. Bak, MD
RTOG 1016:  Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

 For additional information regarding any of these studies please visit Clinicaltrials.gov